Wednesday - March 18, 2026

ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom

While investors chase the obvious opportunity in the emerging GLP-1, MASH Healthcare market, another potentially powerful theme is developing just beneath the surface. Medical Diagnostics If metabolic dysfunction–associated steatohepatitis becomes a widely treated chronic disease, healthcare systems will need to … Continue reading

Gildan Activewear (NYSE: GIL) Model Highlights Opportunity for ADM Endeavors (OTCQB: ADMQ)

The U.S. blank apparel and textile manufacturing industry continues to expand as demand for customizable clothing, uniforms, and branded merchandise accelerates across corporate, promotional, and retail markets. One of the largest players in this space is Gildan Activewear (NYSE: GIL), … Continue reading

Full Alliance (OTCQB: FAGI) Aquaox Pure Solutions’ JusSpray™ Surges on Amazon Demand

Full Alliance Group (OTCQB: FAGI) continues executing its multi-vertical growth strategy as its subsidiary Aquaox Pure Solutions, LLC reports accelerating marketplace traction for JusSpray™, the company’s flagship hypochlorous acid (HOCl) skin defense spray. The product has gained significant momentum on … Continue reading

Novel Scurry (Fraud Squad) Delivers a Pulse-Pounding Fintech Thriller Ripped from the Headlines of Financial Crime. Fintech Fraud Expert Exposes the Dark Side of Silicon Valley’s “996 BRO” Culture

The fintech industry’s ‘move fast and break things’ mentality isn’t just reckless — it’s an open invitation to the most sophisticated financial criminals in the world. Scurry is the story I had to tell — and every scene is grounded … Continue reading